Mangalam Drugs & Organics Limited (BSE: 532637)
Health Care · Pharmaceuticals · IN
Rs31.50
+8.62% today · -55.0% 1Y
Mangalam Drugs & Organics Limited (BSE: 532637) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.15M.
Over the last twelve months the share price has lost 55.0%, trading between 22.70 and 72.95.
Tweenvest scores Mangalam Drugs & Organics Limited across four factors: quality 51/100, value 66/100, growth 0/100. Its strongest factor is value.
532637 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.15M
- Revenue (TTM)
- $24.54M
- P/E
- —
- EPS
- -24.16
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- Rs72.95
- 52-week low
- Rs22.70
- Avg volume (3M)
- —
- Shares outstanding
- 15.83M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Glow Lifetech Corp.CNSX: GLOW | $5.39M | CA$0.04 | -11.11% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.33M | $1.43 | -2.40% |
| Christina Lake Cannabis Corp.CNSX: CLC | $5.22M | CA$0.03 | +20.00% |
| Q/C Technologies, Inc.NasdaqCM: QCLS | $5.16M | $0.58 | -7.48% |
| Blue Wave Water Capital LtdTASE: BLWV-M | $5.13M | ₪2.97 | +26.35% |
| Processa Pharmaceuticals, Inc.NasdaqCM: PCSA | $5.09M | $1.83 | +20.07% |
| Percheron Therapeutics LimitedASX: PER | $5.07M | AU$0.00 | -11.11% |
| Stenocare A/SCPSE: STENO | $5.05M | Dkr0.73 | -6.92% |
Figures last refreshed Oct 11, 2026.